Antonakis N, Markogiannakis E, Theodoropoulou M, Georgoulias V, Stournaras C, Gravanis A
Department of Basic Sciences, School of Medicine, University of Crete, Iraklion, Greece.
J Steroid Biochem Mol Biol. 1991 Dec;39(6):929-35. doi: 10.1016/0960-0760(91)90351-5.
The effects of the antiglucocorticoid RU486 on the expression of low and high affinity interleukin-2 receptors (IL-2R) in phytohaemagglutinin (PHA)-activated human peripheral blood lymphocytes were investigated. We demonstrated that RU486 inhibits in a dose-dependent way the expression of both classes of IL-2R, thereby mimicking the effects of the glucocorticoid agonist dexamethasone. The maximal effect on the low affinity binding sites was observed at 10 microM (28 +/- 2% of control, P less than 0.001) and on the high affinity IL-2R at 1 microM (from 2938 +/- 74 to 437 +/- 108 binding sites per cell, P less than 0.001). This inhibition of IL-2R expression occurs at a pretranslational level since RU486 decreased the accumulation of beta-chain IL-2R mRNA transcripts. Our data support the concept that the antiglucocorticoid RU486 at pharmacological concentrations can exert agonistic-immunosuppressive effects.
研究了抗糖皮质激素RU486对植物血凝素(PHA)激活的人外周血淋巴细胞中低亲和力和高亲和力白细胞介素-2受体(IL-2R)表达的影响。我们证明,RU486以剂量依赖的方式抑制两类IL-2R的表达,从而模拟糖皮质激素激动剂地塞米松的作用。在10微摩尔时观察到对低亲和力结合位点的最大影响(为对照的28±2%,P<0.001),在1微摩尔时对高亲和力IL-2R的最大影响(从每细胞2938±74个结合位点降至437±108个结合位点,P<0.001)。由于RU486降低了β链IL-2R mRNA转录本的积累,这种对IL-2R表达的抑制发生在翻译前水平。我们的数据支持这样一种观点,即药理浓度的抗糖皮质激素RU486可发挥激动剂免疫抑制作用。